EOLS – Evolus, Inc.
Float Short %
13.66
Margin Of Safety %
Put/Call OI Ratio
0.22
EPS Next Q Diff
0.12
EPS Last/This Y
0.42
EPS This/Next Y
0.51
Price
5.07
Target Price
16.5
Analyst Recom
1.29
Performance Q
-25.18
Relative Volume
0.76
Beta
1.14
Ticker: EOLS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | EOLS | 6.91 | 0.03 | 0.00 | 7975 |
| 2025-12-29 | EOLS | 6.66 | 0.03 | 5.45 | 8083 |
| 2025-12-30 | EOLS | 6.66 | 0.04 | 0.00 | 8149 |
| 2025-12-31 | EOLS | 6.66 | 0.04 | 0.02 | 8231 |
| 2026-01-02 | EOLS | 6.73 | 0.03 | 1.72 | 8386 |
| 2026-01-05 | EOLS | 6.06 | 0.04 | 0.23 | 8451 |
| 2026-01-06 | EOLS | 5.92 | 0.05 | 0.41 | 8692 |
| 2026-01-07 | EOLS | 5.7 | 0.06 | 0.07 | 9061 |
| 2026-01-08 | EOLS | 5.74 | 0.06 | 0.20 | 9208 |
| 2026-01-09 | EOLS | 5.66 | 0.07 | 0.20 | 9273 |
| 2026-01-12 | EOLS | 5.76 | 0.07 | 0.35 | 9488 |
| 2026-01-13 | EOLS | 5.74 | 0.07 | 0.02 | 9665 |
| 2026-01-14 | EOLS | 5.02 | 0.07 | 1.04 | 9665 |
| 2026-01-15 | EOLS | 5 | 0.12 | 0.61 | 10438 |
| 2026-01-16 | EOLS | 5.2 | 0.13 | 1.31 | 10688 |
| 2026-01-20 | EOLS | 5.05 | 0.37 | 0.01 | 4745 |
| 2026-01-21 | EOLS | 4.89 | 0.23 | 0.04 | 6912 |
| 2026-01-22 | EOLS | 5.07 | 0.22 | 0.15 | 7086 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | EOLS | 6.91 | 302.9 | 36.5 | -0.39 |
| 2025-12-29 | EOLS | 6.66 | 302.9 | 36.6 | -0.39 |
| 2025-12-30 | EOLS | 6.66 | 302.9 | 36.6 | -0.39 |
| 2025-12-31 | EOLS | 6.67 | 302.9 | 36.6 | -0.39 |
| 2026-01-02 | EOLS | 6.72 | 302.9 | 36.5 | -0.39 |
| 2026-01-05 | EOLS | 6.06 | 302.9 | 36.6 | -0.39 |
| 2026-01-06 | EOLS | 5.91 | 302.9 | 36.6 | -0.39 |
| 2026-01-07 | EOLS | 5.66 | 302.9 | 36.6 | -0.39 |
| 2026-01-08 | EOLS | 5.74 | 302.9 | 36.5 | -0.39 |
| 2026-01-09 | EOLS | 5.66 | 302.9 | 36.6 | -0.39 |
| 2026-01-12 | EOLS | 5.76 | 302.9 | 36.5 | -0.39 |
| 2026-01-13 | EOLS | 5.74 | 302.9 | 36.6 | -0.39 |
| 2026-01-14 | EOLS | 5.01 | 302.9 | 36.6 | -0.39 |
| 2026-01-15 | EOLS | 4.99 | 302.9 | 36.6 | -0.39 |
| 2026-01-16 | EOLS | 5.20 | 313.7 | 36.5 | -0.39 |
| 2026-01-20 | EOLS | 5.05 | 313.7 | 36.6 | -0.39 |
| 2026-01-21 | EOLS | 4.89 | 313.7 | 36.6 | -0.39 |
| 2026-01-22 | EOLS | 5.07 | 313.7 | 36.5 | -0.39 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | EOLS | 0.16 | -10.16 | 12.78 |
| 2025-12-29 | EOLS | 0.16 | -10.16 | 12.78 |
| 2025-12-30 | EOLS | 0.08 | -10.16 | 12.78 |
| 2025-12-31 | EOLS | 0.08 | -10.16 | 12.78 |
| 2026-01-02 | EOLS | 0.08 | -10.16 | 12.78 |
| 2026-01-05 | EOLS | 0.08 | -10.20 | 12.78 |
| 2026-01-06 | EOLS | 0.08 | -10.20 | 12.78 |
| 2026-01-07 | EOLS | 0.08 | -10.20 | 12.78 |
| 2026-01-08 | EOLS | 0.08 | -10.20 | 12.78 |
| 2026-01-09 | EOLS | 0.08 | -10.20 | 12.78 |
| 2026-01-12 | EOLS | 0.07 | -10.20 | 12.78 |
| 2026-01-13 | EOLS | 0.08 | -10.20 | 13.66 |
| 2026-01-14 | EOLS | 0.08 | -10.20 | 13.66 |
| 2026-01-15 | EOLS | 0.08 | -10.20 | 13.66 |
| 2026-01-16 | EOLS | 0.08 | -10.20 | 13.66 |
| 2026-01-20 | EOLS | 0.08 | -9.96 | 13.66 |
| 2026-01-21 | EOLS | 0.08 | -9.96 | 13.66 |
| 2026-01-22 | EOLS | 0.08 | -9.96 | 13.66 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.2
Avg. EPS Est. Current Quarter
0.06
Avg. EPS Est. Next Quarter
-0.08
Insider Transactions
0.08
Institutional Transactions
-9.96
Beta
1.14
Average Sales Estimate Current Quarter
90
Average Sales Estimate Next Quarter
74
Fair Value
Quality Score
30
Growth Score
49
Sentiment Score
15
Actual DrawDown %
71.6
Max Drawdown 5-Year %
-72
Target Price
16.5
P/E
Forward P/E
PEG
P/S
1.15
P/B
P/Free Cash Flow
EPS
-0.91
Average EPS Est. Cur. Y
-0.39
EPS Next Y. (Est.)
0.13
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-20.49
Relative Volume
0.76
Return on Equity vs Sector %
176.4
Return on Equity vs Industry %
196.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
36.5
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 329
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading